he proof of efficacy of MT on PLP is so far inadequate to recommend it as a first-line treatment. Randomised controlled trials are still needed to assess the effects of MT more thoroughly, on both pain and the integration and use of the prosthetic limb, and also to determine the optimal terms for its applicati